VIRIDIAN THERAPEUTICS INC (VRDN) Stock Balance Sheet
NASDAQ:VRDN - Nasdaq - US92790C1045 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 116.22M | 99.59M | 102.83M | 155.60M | 42.30M | |||
| Marketable Securities | 520.42M | 617.99M | 374.54M | 269.00M | 154.70M | |||
| Receivables | N/A | 0.00 | 102.00K | 100.00K | 500.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 20.61M | 20.88M | 9.01M | 6.50M | 2.70M | |||
| Total Current Assets | 657.24M | 738.46M | 486.48M | 431.20M | 200.20M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.25M | 3.44M | 3.34M | 2.90M | 2.10M | |||
| Other Non-Current Assets | 489.00K | 501.00K | 604.00K | 1.00M | 1.50M | |||
| Total Non-Current Assets | 3.74M | 3.94M | 3.95M | 3.90M | 3.50M | |||
| TOTAL ASSETS | 660.98M | 742.40M | 490.42M | 435.10M | 203.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 29.55M | 45.44M | 24.11M | 18.80M | 11.00M | |||
| Accounts Payable | 3.89M | 2.14M | 2.24M | 14.20M | 2.30M | |||
| Other Current Liabilities | 288.00K | 288.00K | 288.00K | 300.00K | 300.00K | |||
| Total Current Liabilities | 33.73M | 47.87M | 26.64M | 33.30M | 13.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 20.68M | 20.58M | 20.20M | 4.60M | 0.00 | |||
| Other Non-Current Liabilities | 2.10M | 2.31M | 1.56M | 2.00M | 2.40M | |||
| Total Non-Current Liabilities | 22.78M | 22.89M | 21.77M | 6.70M | 2.40M | |||
| TOTAL LIABILITIES | 56.51M | 70.76M | 48.40M | 40.00M | 16.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.08B | -995.86M | -725.91M | -488.20M | -358.30M | |||
| Additional Paid In Capital | 1.50B | 1.48B | 960.54M | 741.10M | 412.10M | |||
| Common Shares | 189.70M | 189.69M | 207.06M | 142.60M | 134.10M | |||
| Other Shareholders' Equity | 245.00K | -10.00K | 338.00K | -400.00K | -200.00K | |||
| Shares Outstanding | 81.59M | 80.99M | 53.99M | 41.30M | 23.90M | |||
| Tangible Book Value per Share | 5.09 | 5.96 | 4.36 | 6.12 | 2.25 | |||
| Total Shareholders' Equity | 604.47M | 671.64M | 442.02M | 395.10M | 187.70M | |||
| TOTAL LIABILITIES AND EQUITY | 660.98M | 742.40M | 490.42M | 435.10M | 203.70M | |||
| Statistics | ||||||||
| Debt/Equity | 0.03 | 0.03 | 0.05 | 0.01 | N/A | |||
| Current Ratio | 19.49 | 15.43 | 18.26 | 12.95 | 14.72 | |||
| Return On Assets (ROA) | -46.65% | -36.36% | -48.48% | -29.85% | -38.98% | |||
| Return On Equity (ROE) | -51.01% | -40.19% | -53.78% | -32.87% | -42.31% | |||
All data in USD , ROIC based on taxRate of 0.21